CD274 and cancer: With the in-depth understanding of tumor immune escape mechanism, immune checkpoint inhibitors represented by Programmed Death 1/Programmed cell Death-Ligand 1(PD-1/PD-L1) inhibitors are becoming increasingly significant in cancer medication treatment (Li et al., 2021).